Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-stage Study to Evaluate Single Doses of MZ-004 at Different Dose Levels in Patients With Chronic Total Occlusions. Stage 1: Open Label Training Stage. Stage 2: Double-blind, Randomized, Placebo-Controlled Stage

NCT01753180 is registered in ClinicalTrials.gov with Matrizyme Pharma Corporation as lead sponsor.

NCT NCT01753180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-stage Study to Evaluate Single Doses of MZ-004 at Different Dose Levels in Patients With Chronic Total Occlusions. Stage 1: Open Label Training Stage. Stage 2: Double-blind, Randomized, Placebo-Controlled Stage
Lead sponsor
Matrizyme Pharma Corporation
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
July 31, 2016
Enrollment
76 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary total occlusions